Apex Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$531K Hold
3,540
0.01% 230
2015
Q4
$575K Sell
3,540
-11
-0.3% -$1.73K 0.01% 208
2015
Q3
$491K Buy
3,551
+11
+0.3% +$1.73K 0.01% 217
2015
Q2
$543K Hold
3,540
0.01% 220
2015
Q1
$566K Hold
3,540
0.01% 216
2014
Q4
$564K Hold
3,540
0.02% 206
2014
Q3
$497K Buy
3,540
+40
+1% +$5.22K 0.02% 210
2014
Q2
$414K Hold
3,500
0.01% 235
2014
Q1
$432K Hold
3,500
0.02% 222
2013
Q4
$400K Hold
3,500
0.02% 221
2013
Q3
$392K Hold
3,500
0.02% 204
2013
Q2
$345K Buy
+3,500
New +$363K 0.02% 198

Other funds holding AMGN

Apex Capital Management's AMGN Position: Q1 2016 in Review

Apex Capital Management held its Amgen (AMGN) position steady in Q1 2016 at 3,540 shares worth $531K. The position accounts for 0.01% of the portfolio, ranked #230.

Apex Capital Management first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $575K in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Apex Capital Management held 3,540 shares of Amgen worth $531K as of Q1 2016.
  • Apex Capital Management left its Amgen share count unchanged in Q1 2016.
  • Amgen made up 0.01% of Apex Capital Management's portfolio in Q1 2016, its #230 holding.
  • Apex Capital Management first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
  • Apex Capital Management's Amgen position peaked at $575K in Q4 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.